These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 6933939

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of atenolol in relation to renal function.
    Kirch W, Köhler H, Mutschler E, Schäfer M.
    Eur J Clin Pharmacol; 1981 Jan; 19(1):65-71. PubMed ID: 7461026
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics, pharmacology of atenolol and effect of renal disease.
    Wan SH, Koda RT, Maronde RF.
    Br J Clin Pharmacol; 1979 Jun; 7(6):569-74. PubMed ID: 465278
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Kinetics of cefsulodin in patients with renal impairment.
    Gibson TP, Granneman GR, Kallal JE, Sennello LT.
    Rev Infect Dis; 1984 Jun; 6 Suppl 3():S689-97. PubMed ID: 6571338
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Atenolol kinetics in renal failure.
    McAinsh J, Holmes BF, Smith S, Hood D, Warren D.
    Clin Pharmacol Ther; 1980 Sep; 28(3):302-9. PubMed ID: 7408390
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Studies on the pharmacokinetics and pharmacodynamics of atenolol in man.
    Fitzgerald JD, Ruffin R, Smedstad KG, Roberts R, McAinsh J.
    Eur J Clin Pharmacol; 1978 May 17; 13(2):81-9. PubMed ID: 658112
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.
    Brown HC, Carruthers SG, Johnston GD, Kelly JG, McAinsh J, McDevitt DG, Shanks RG.
    Clin Pharmacol Ther; 1976 Nov 17; 20(5):524-34. PubMed ID: 10125
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of atenolol in hypertensive subjects with and without co-administration of chlorthalidone.
    Riva E, Farina PL, Sega R, Tognoni G, Bastain W, McAinsh J.
    Eur J Clin Pharmacol; 1980 May 17; 17(5):333-7. PubMed ID: 7418712
    [Abstract] [Full Text] [Related]

  • 16. Effects of impaired renal function, hemodialysis, and peritoneal dialysis on the pharmacokinetics of mezlocillin.
    Kampf D, Schurig R, Weihermüller K, Förster D.
    Antimicrob Agents Chemother; 1980 Jul 17; 18(1):81-7. PubMed ID: 6448024
    [Abstract] [Full Text] [Related]

  • 17. The influence of renal function on plasma levels and urinary excretion of acebutolol and its main N-acetyl metabolite.
    Kirch W, Köhler H, Berggren G, Braun W.
    Clin Nephrol; 1982 Aug 17; 18(2):88-94. PubMed ID: 7140021
    [Abstract] [Full Text] [Related]

  • 18. The pharmacokinetics of metoprolol and its metabolites in dialysis patients.
    Seiler KU, Schuster KJ, Meyer GJ, Niedermayer W, Wassermann O.
    Clin Pharmacokinet; 1980 Aug 17; 5(2):192-8. PubMed ID: 7363534
    [Abstract] [Full Text] [Related]

  • 19. Metabolism of atenolol in man.
    Reeves PR, McAinsh J, McIntosh DA, Winrow MJ.
    Xenobiotica; 1978 May 17; 8(5):313-20. PubMed ID: 27019
    [Abstract] [Full Text] [Related]

  • 20. Clinical pharmacokinetics of atenolol.
    McAinsh J.
    Postgrad Med J; 1977 May 17; 53 Suppl 3():74-8. PubMed ID: 928270
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.